Drug Approval Package
Relenza (zanamivir for
inhalation)
Company: Glaxo Wellcome Inc.
Application No.: 021036S001
Approval Date: 4/26/2000
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Medical Review(s) (PDF)
-
Chemistry Review(s) (PDF)
-
Pharmacology Review(s) (PDF)
-
Statistical Review(s) (PDF)
-
Microbiology Review(s) (PDF)
-
Administrative Document(s) & Correspondence
Part 1 (PDF)
Part 2 (PDF)
Date created: April 122004
Note: Documents in PDF format require the Adobe Acrobat Reader®.